Evidence map›Paper›PMID 36986870›Full record

ArticlePharmaceutics2023

pH-Dependent Behavior of Novel 5-FU Delivery System in Environmental Conditions Comparable to the Gastro-Intestinal Tract.

Geza Lazar, Fran Nekvapil, Branko Glamuzina, Tudor Tamaș, Lucian Barbu-Tudoran, Maria Suciu, Simona Cinta Pinzaru

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Geza LazarBiomolecular Physics Department, Faculty of Physics, Babes Bolyai University, Kogalniceanu 1, 400084 Cluj-Napoca, Romania.
Fran NekvapilBiomolecular Physics Department, Faculty of Physics, Babes Bolyai University, Kogalniceanu 1, 400084 Cluj-Napoca, Romania.ORCID 0000-0001-8652-8292
Branko GlamuzinaDepartment of Applied Ecology, University of Dubrovnik, Ćira Carića 4, 20 000 Dubrovnik, Croatia.ORCID 0000-0002-5066-4599
Tudor TamașDepartment of Geology, Babeş-Bolyai University, 1 Kogălniceanu, 400084 Cluj-Napoca, Romania.ORCID 0000-0002-7032-5447
Lucian Barbu-TudoranElectron Microscopy Centre, Babeș-Bolyai University, Clinicilor 5-7, 400006 Cluj-Napoca, Romania.ORCID 0000-0003-0360-016X
Maria SuciuAdvanced Research and Technology Center for Alternative Energy, National Institute for Research and Development of Isotopic and Molecular Technologies, Donat 67-103, 400293 Cluj-Napoca, Romania.
Simona Cinta PinzaruBiomolecular Physics Department, Faculty of Physics, Babes Bolyai University, Kogalniceanu 1, 400084 Cluj-Napoca, Romania.ORCID 0000-0001-8016-4408
Babeș-Bolyai University · RONational Institute for Research and Development of Isotopic and Molecular Technologies · ROUniversity of Dubrovnik · HR

Funding

Ministerul Cercetării și Inovării PN-III-P2-2.1-PED-2019-4777, Nr. 377 PED/ 2020
6 · The paper itself

Abstract

A biogenic carrier for 5-fluorouracil (5-FU) loading and subsequent tableting as a new drug formulation for slow release has been proposed using the biomineral from blue crab carapace. Due to its highly ordered 3D porous nanoarchitecture, the biogenic carbonate carrier could achieve increased effectiveness in colorectal cancer cure provided that the formulation would successfully pass through the gastric acid conditions. Following the recently proven viability of the concept by demonstrating the slow release of the drug from the carrier using the highly sensitive SERS technique, here we investigated the 5-FU release from the composite tablet drug in pH conditions replicating the gastric environment. The released drug from the tablet was studied in solutions with three relevant pH values, pH 2, pH 3, and pH 4. The 5-FU SERS spectral signature for each pH value was used to build calibration curves for quantitative SERS analysis. The results suggested a similarly slow-releasing pattern in acid pH environments to that in neutral conditions. Although biogenic calcite dissolution was expected in acid conditions, the X-ray diffraction and Raman spectroscopy showed preservation of calcite mineral along with the monohydrocalcite during acid solution exposure for two hours. The total released amount in a time course of seven hours, however, was lower in acidic pH solutions, with a maximum fraction of ~40% of the total amount of loaded drug, for pH 2, as opposed to ~80% for neutral values. Nonetheless, these results clearly prove that the novel composite drug retains its slow-releasing character in environmental conditions compatible with the gastrointestinal pH and that it is a viable and biocompatible alternative for oral delivery of anticancer drug to reach the lower gastro-intestinal tract.

Indexed as

drug carriernovel pharmaceutical formulationpH-dependent releaseSERS

Identifiers

PMID36986870
PMCPMC10056423
OpenAlexW4353074416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.